| 초록 |
Purpose: The present study aimed to investigate the impact of high-sensitivity C-reactive protein (hs-CRP) and renal
dysfunction on clinical outcomes in acute myocardial infarction (AMI) patients.
Materials and Methods: The study involved a retrospective cohort of 8,332 patients admitted with AMI. The participants
was divided into 4 groups according to levels of estimated glomerular filtration rate (eGFR) and hs-CRP: group I, no
renal dysfunction (eGFR ≥ 60 mL•min-1•1.73m2) with low hs-CRP (≤2.0 mg/dL); group II, no renal dysfunction with
high hs-CRP; group III, renal dysfunction with low hs-CRP; and group IV, renal dysfunction with high hs-CRP. We
compared major adverse cardiac events (MACE) over a 1-y follow-up period.
Results: The 4 groups demonstrated a graded association with increased MACE rates. (group I, 8.8%; group II, 13.8
%; group III, 18.6%; group IV, 30.1%; p<0.001). In a Cox proportional hazards model, mortality at 12 months increased
in groups II, III, and IV compared with group I (hazard ratio [HR] 2.038, 95% confidence interval [CI] 1.450-
2.863, p<0.001; HR 3.003, 95% CI 2.269-3.974, p<0.001; HR 5.087, 95% CI 3.755-6.891, p<0.001).
Conclusion: High hs-CRP, especially in association with renal dysfunction, is related the occurrence of composite
MACE and indicates poor prognosis in AMI patients. |